Top
image: healthline

Blood test for genetic changes may predict leukaemia early

Researchers from Wellcome Sanger Institute and European Bioinformatics Institute (EMBL-EBI) have revealed that a blood test for changes in the DNA code can help predict a patient’s risk of developing acute myeloid leukaemia (AML) years before a positive diagnosis.

During a study conducted in collaboration with international scientists, the UK researchers observed genetic changes in the blood of AML patients, years prior to their abrupt development of the cancer.

Read More on medicaldevice-network.com